These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28368997)

  • 41. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glaucoma prescribing trends in England 2000 to 2012.
    Connor AJ; Fraser SG
    Eye (Lond); 2014 Jul; 28(7):863-9. PubMed ID: 24858531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Water-drinking test in patients with primary open-angle glaucoma while treated with different topical medications.
    Vetrugno M; Sisto D; Trabucco T; Balducci F; Delle Noci N; Sborgia C
    J Ocul Pharmacol Ther; 2005 Jun; 21(3):250-7. PubMed ID: 15969643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of benzalkonium chloride-free travoprost on intraocular pressure and ocular surface symptoms in patients with glaucoma previously on latanoprost: an open-label study.
    Lopes JF; Hubatsch DA; Amaris P
    BMC Ophthalmol; 2015 Nov; 15():166. PubMed ID: 26563363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
    Liu JH; Medeiros FA; Slight JR; Weinreb RN
    Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antihypertensive use, prescription patterns, and cost of medications in a Teaching Hospital in Lagos, Nigeria.
    Bakare OQ; Akinyinka MR; Goodman O; Kuyinu YA; Wright OK; Adeniran A; Odusanya OO; Osibogun A
    Niger J Clin Pract; 2016; 19(5):668-72. PubMed ID: 27538558
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of central corneal thickness on the efficacy of topical ocular hypotensive medications.
    Johnson TV; Toris CB; Fan S; Camras CB
    J Glaucoma; 2008 Mar; 17(2):89-99. PubMed ID: 18344753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of Patients Receiving Treatment Who Deny A Diagnosis Glaucoma or Elevated Intraocular Pressure in the United States.
    Lowry EA; Mansberger SL
    J Glaucoma; 2018 Nov; 27(11):1029-1031. PubMed ID: 30059410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Meibomian Gland Performance in Glaucomatous Patients With Long-term Instillation of IOP-lowering Medications.
    Cho WH; Lai IC; Fang PC; Chien CC; Tseng SL; Lai YH; Huang YT; Kuo MT
    J Glaucoma; 2018 Feb; 27(2):176-183. PubMed ID: 29240600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prescription patterns and costs of acne/rosacea medications in Medicare patients vary by prescriber specialty.
    Zhang M; Silverberg JI; Kaffenberger BH
    J Am Acad Dermatol; 2017 Sep; 77(3):448-455.e2. PubMed ID: 28651825
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Costs and effectiveness of travoprost versus a dorzolamide + timolol fixed combination in first-line treatment of glaucoma: analysis conducted on the United Kingdom General Practitioner Research Database.
    Lafuma A; Berdeaux G
    Curr Med Res Opin; 2007 Dec; 23(12):3009-16. PubMed ID: 17958945
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A randomized, 36-month, post-marketing efficacy and tolerability study in Sweden and Finland of latanoprost versus non-prostaglandin therapy in patients with glaucoma or ocular hypertension.
    Friström B; Uusitalo H
    Acta Ophthalmol; 2010 Feb; 88(1):37-43. PubMed ID: 19900212
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Sezgin Akçay Bİ; Güney E; Bozkurt KT; Unlü C; Akçali G
    J Ocul Pharmacol Ther; 2013 Dec; 29(10):882-6. PubMed ID: 24180628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The future is old - Patients with topical ocular hypotensive treatment in the Nordic region between 2008 and 2017 with projections for 2040.
    Bro T; Wickström K; Lindén C
    Acta Ophthalmol; 2021 Dec; 99(8):e1442-e1448. PubMed ID: 33720517
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K; Ito K; Okawa C; Sugimoto K; Matsunaga K; Uji Y
    J Glaucoma; 2008; 17(3):233-7. PubMed ID: 18414111
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New chronic disease medication prescribing by nurse practitioners, physician assistants, and primary care physicians: a cohort study.
    Marcum ZA; Bellon JE; Li J; Gellad WF; Donohue JM
    BMC Health Serv Res; 2016 Jul; 16():312. PubMed ID: 27464570
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the efficacy and safety of dorzolamide 2% when added to brimonidine 0.2% or timolol maleate 0.5% in patients with primary open-angle glaucoma.
    Oztürk F; Ermiş SS; Inan UU; Aşagidag A; Yaman S
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):68-74. PubMed ID: 15718830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical prostaglandin fixed combinations in UK primary care: observational study using data from the health improvement network.
    Loftus J; Christopoulou D; Blak BT; Hards M
    Eur J Ophthalmol; 2012; 22(3):376-87. PubMed ID: 22034021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term effects of brimonidine/timolol and dorzolamide/timolol on ocular perfusion pressure and blood flow in glaucoma.
    Siesky B; Harris A; Ehrlich R; Cantor L; Shoja MM; Rusia D; Hollander DA; Abrams L; Williams JM; Shoshani Y
    Adv Ther; 2012 Jan; 29(1):53-63. PubMed ID: 22246943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.